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ABSTRACT
    Vitamin D is reported to affect immune system and prevent autoimmunity. Some studies show that low vita -
min D levels in patients with type 1 diabetes are associated with glycemic control and inflammatory status. The
study was cross sectional design with subjects T1DM patients aged 1-18 years, and healthy subjects with similar
age. Plasma levels of vitamin D (25(OH)D3) was measured using ELISA. Glycemic control measured by hemoglo-
bin A1c (HbA1c). Inflammatory status measured by examination of IL-10 using ELISA method. Comparison of
vitamin D levels, HbA1c levels and IL-10 levels were analyzed by independent samples t-test. The relationship be -
tween vitamin D levels, HbA1c, and IL-10 were analyzed by Pearson's correlation. Our subjects were 20 T1DM
patients and 20 healthy controls. Our study showed that vitamin D (25(OH)D3) levels was significantly lower
than in healthy controls (20.82±5.53 ng/ml vs 33.14±2.17 ng/ml; p=0.000), HbA1c levels was significantly higher
than in healthy controls  (10.08±5.02% vs  5.02±0.18%; p=0.000),  IL-10 levels  was  significantly  lower than in
healthy controls (16.50±4.57 ng/ml vs 73.52±7.11 ng/ml; p=0.000). Vitamin D levels were correlated with HbA1c
(p= 0.000; r= -0.871), correlated with IL-10 (p= 0.000; r= 0.853).  HbA1c levels were correlated with IL-10 levels
(p= 0.000; r= -0.878). Low vitamin D levels are common in T1DM patients. There were significant differences in
vitamin D levels, IL-10, and HbA1c among T1DM patients compared to normal subjects. Vitamin D levels were
associated with HbA1c levels and IL-10 levels in T1DM.
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Type 1 diabetes results from autoimmune destruc-
tion of  insulin-producing  β cells  in the islets  of  the
pancreas [1]. Failure mechanisms of immunoregulator
cause autoreactive T cells, inflammatory process in the
islets and damage the pancreatic  β cell [2,3]. Vitamin
D deficiency may increase the risk of developing au-
toimmune diseases including type 1 diabetes mellitus.
This occurs due to loss of modulation of vitamin D on
the immune system and inflammatory reactions in dia-
betes [4]. The role of vitamin D as an immunomodula-
tor  can  be  explained  by  several  mechanisms  that
vitamin D plays a role in dendritic cells that play a cen-
tral role in the immune response mediated T cells acti -
vation, modifying T cell differentiation, induce the se-
cretion of  cytokines,  which decrease the secretion of
pro-inflammatory cytokines such as interleukin-12 (IL-
12) and increased anti-inflammatory cytokines such as
interleukin-10 (IL-10). Vitamin D also acts directly on
T cells to promote IL-10 secreting Tregs. IL-10 is an
anti  inflammatory  cytokine  that  has  the  potential
downregulation  activity  of  the  inflammatory  process
[5,6].
Indonesia is  a tropical  climate country where In-
donesian people will not come through vitamin D defi-
ciency [7]. When there is a relationship between vita-
min D deficiency and glycemic control of type 1 dia-
betes mellitus, Indonesian children should have good
glycemic  control,  whereas  today  they  found  poor
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glycemic control [8]. Therefore the aim of this study
was to determine the relationship between vitamin D
levels with HbA1c level and IL-10 level in T1DM.
This cross sectional study was conducted in T1DM
children attending the Pediatric Endocrinology Clinic,
Department  of  Pediatrics,  Saiful  Anwar  Hospital
Malang from January to March 2014. Twenty children
with  established  T1DM  and  20  healthy  subject
matched age were recruited as controls. The study was
approved by the ethics committee of Brawijaya Univer-
sity  School  of  Medicine,  Saiful  Anwar  Hospital
Malang, Indonesia and informed consent was obtained
from all  participants.  Diabetic  children  with  impair-
ment of liver function, renal function, anemia, infec-
tion, other autoimmune disease or those on vitamin D
supplementation were excluded. Likewise, healthy chil-
dren who were on vitamin D were excluded. All pa-
tients underwent baseline investigation for hematologic
and biochemical laboratory parameters.
Vitamin D measurement
Vitamin D (25(OH)D3) level was assesed using En-
zyme Linked Immunosorbent Assay in accordance with
the manufacturer's instruction (Orgentec, Alegria, Ger-
many).  The Alegria® assay features barcoded 8-well-
microstrips, called Alegria® Test Strips. Each strip is
designed for a single determination of one patient sam-
ple. The Alegria® Test Strip holds a complete set of
reagents. Included are enzyme conjugate, enzyme sub-
strate, sample buffer and a test  specific control.  Two
wells of the Alegria® Test Strip are coated with a 25-
OH vitamin  D3/D2  antibody  and  serve  as  reaction
wells  for  one  control  and  one  patient  sample.  Two
more wells of the Alegria® Test Strip are coated with a
25-OH vitamin D tracer or a 25-OH vitamin D control
respectively. The determination is based on a competi-
tive enzyme linked immunosorbent assay (ELISA) with
the following steps: The sample is pipetted into well
No 1.  Inside the Alegria® Random Access  Analyser
the sample is mixed with tracer reagent and the 25-OH
vitamin D3/D2 is  delivered  from vitamin D binding
protein. 25-OH vitamin D and tracer reagent coated in
well No 2 are suspended with buffer. Sample and con-
trol are then transferred to the reaction wells No 3 and
No 4 where 25-OH vitamin D3/D2 and 25-OH vita-
min D tracer reagent compete for binding to the coated
25-OH  vitamin  D3/D2  antibody.  Complexes  are
formed between 25-OH vitamin D3/D2 and antibody
or 25-OH vitamin D tracer reagent and antibody. After
incubation, a first washing step removes unbound and
unspecifically  bound  molecules.  Subsequently  added
enzyme conjugate binds to the immobilized tracer-anti-
body complexes.  After  incubation,  a  second washing
step removes unbound enzyme conjugate. Addition of
enzyme substrate solution results in hydrolisation and
color development during incubation. The intensity of
the blue color can be measured photometrically at 650
nm. Vitamin D insufficiency defined as a level 20-30
ng/ml,  vitamin  D  deficiency  as  level  <  20  ng/ml,
whereas normo vitamin D as level > 30 ng/ml [9].
HBA1c measurement
HbA1c  level  was  assesed  by  BioRad  D-10.  Pro-
gram utilizes principles of ion exchange high perfor-
mance  liquid  chromatography  (HPLC).  The  samples
are automatically diluted on the D-10 and injected into
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the  analytical  cartridge.  The  D-10  delivers  a  pro-
grammed buffer gradient of increasing ionic strength
to the cartridge, where the hemoglobins are separated
based on their ionic interactions with cartridge mate-
rial. If there is less than 2 ml of sample in the tube,
then the sample must be prediluted. Before pipetting,
thoroughly  mix  the  sample  by  gently  inverting  the
tube. To predilute, pipet 1.5 ml of wash/ diluent solu-
tion into a labeled 1.5 ml vial, followed by 5 µL of the
whole blood sample. Cap the sample vial and mix thor-
oughly. The separated hemoglobins then pass through
the flow cell of the filter photometer, where changes in
the absorbance at 415 nm are measured.  
IL-10 measurement
Levels of  IL-10 were measured using Human IL-
10 Quantikine ELISA kits according to the R&D Sys-
tems (Minneapolis, MN, USA) manufacturer’s instruc-
tions.This assay employs the quantitative sandwich en-
zyme immunoassay technique. A monoclonal antibody
specific  for  IL-10  has  been  pre-coated  onto  a  mi-
croplate. Standards and samples are pipetted into the
wells and any IL-10 present is bound by the immobi-
lized antibody. After washing away any unbound sub-
stances,  an  enzyme-linked  monoclonal  antibody  spe-
cific for IL-10 is added to the wells. Following a wash
to  remove any unbound antibody-enzyme reagent,  a
substrate solution is added to the wells and color devel-
ops in proportion to the amount of IL-10 bound in the
initial step. The color development is stopped and the
intensity of the color is measured. Samples were ana-
lyzed and compared with control samples.
Statistical analysis
The results were analyzed using appropriate statis-
tical  tests  on  Statistical  Package  for  Social  Sciences
(SPSS)  software.  Quantitative  data  was  expressed  as
mean ± 2 standard deviation (SD).  Statistical  signifi-
cance of quantitative variables between different cate-
gories  was  analysed using independent  sample t-test.
Pearson’s correlation coefficient (r) was used to indi-
cate significant linear relationship among quantitative
variables. A p value <0.05 was considered as significant.
Of  the  total  number  of  children  surveyed,  13
T1DM and 13 of  the healthy children were females.
The  mean  age  for  diabetics  versus  controls  was
12.1±3.1 years versus 10.5±2.6 years (Table 1). 
The result of hematological and biochemical labora-
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tory measurement are shown in table 2. From the labo-
ratory  results  showed  high  levels  of  HbA1c
(10.08±2.28), 14 out of 20 had poor metabolic control
(HbA1c > 9%), 12 T1DM patients with vitamin D defi-
ciency, 6 patients with vitamin D insufficiency, and 2
patients with normal level of vitamin D, other result of
hematological and biochemical parameters showed as
normal level. 
Mean  of  vitamin  D  (25(OH)D3)  level  was
33.14±2.17  ng/ml  in  the  normal  control,  and
20.82±5.53 in T1DM group (p=0.000) (table 3). Mean
HbA1c level was 5.02±0.18 % in the normal control,
and 10.08±5.02  in  T1DM group (p=0.000)  (table  3).
Mean IL-10 level was 73.52±7.11 pg/ml in the normal
control,  and  16.50±4.57  in  T1DM group   (p=0.000)
(table  3).  There  was  correlation  between  25(OH)D3
level and HbA1c level (p=0.000; r=-0.871), IL-10 level
(p=0.000;  r=  0.853).  HbA1c levels  in patients  T1DM
was correlated with levels of IL-10 (p 0.000; r=-0.878).
This  is  consistent  with  previous  epidemiological
data with peak incidence occurs during puberty [10].
Based on the sex distribution was found that most fe-
males (13 out of 20). The incidence of type 1 DM in
Indonesia with a sex ratio of female than male 45:55
[11].  The mean insulin dose  used in  our study was
1.18±0.25. In contrast to the study by Batubara et al11
(1.0±0.3)  IU/kg/day,  the study group Hvidoere (1.0±
0.3)  IU/kg/day  [12].   HbA1c  levels  (HbA1c=10.08±
2.28) was showed poor metabolic control. This is simi-
lar  to  research  in  Tanzania  obtained  with  a  mean
HbA1c levels were still high (12.6±3.5 %)13, similarly a
study done in Sudan where Elamin et al. found a high
incidence  of  poor  glycemic  control  estimated  by
HbA1c [14]. Most likely the underlying cause is the as-
sociation between limited insulin supply  and lack of
self-monitoring of blood glucose. Furthermore, in addi-
tion to limited insulin supply, patients reduce their in-
sulin  dose  to ensure  longer  periods  of  insulin  treat-
ment.  Nevertheless,  insulin  storage  might  also  influ-
ence the effect of the insulin, as many families store
the insulin in a pot with cold water, exposing the in-
sulin to high temperatures. Storage of insulin may in-
fluence  the effects  of  insulin.  Insulin  must  never  be
frozen.  Direct sunlight or warming (in hot  climates)
damages insulin. Patients should not use insulins that
have changed in appearance (clumping, frosting, pre-
cipitation, or discolouration). Unused insulin should be
stored in a refrigerator (4-8 0C). After first usage, an
insulin vial should be discarded after 3 months if kept
at  2-8  0C or  4  weeks  if  kept  at  room temperature.
However, for some insulin preparations, manufacturers
recommend only 10-14 days of use in room tempera-
ture [13-15].
Vitamin  D  levels  of  T1DM patients  was  signifi-
cantly lower than healthy controls (p=0.000). Of the 20
subjects of T1DM, 12 out of 20 with a deficiency of vi-
tamin D, 6 out of 20 vitamin D insufficiency, and 2 out
of  20  with  normal  levels,  whereas  all  subject  in  the
control group with normal vitamin D levels. Our study
similar with study in Switzerland, in a cross-sectional
study,  60–84% of  T1DM were  25(OH)D3  deficient
[16]. In Qatar, in a case control study, 90.6% of T1DM
children versus 85.3% of nondiabetic children had vita-
min D deficiency [17]. Similarly, in North India in a
case-control  study,  58% of  T1DM and only  32% of
controls had 25(OH)D3 deficiency [18]. In Northeast-
ern US, in a cross-sectional study, it has been found
that 15% of T1DM patients were 25(OH)D3 deficient
and 61% were insufficient, findings inversely associated
with age Low vitamin D levels in type 1 diabetes is
likely to be influenced by immunomodulatory system
[19]. Immunomodulatory functions of vitamin D is the
ability to inhibit the expression of Th1 cytokines, en-
hance the role of Th2 cytokines through directly act on
T cells or indirectly through APCs [20]. Vitamin D af-
fects Th cell polarization by inhibiting Th1 (IFN-γ pro-
duction) and augmenting Th2 cell development (IL-4,
IL-5, and IL-10 production). Vitamin D acts directly on
Th cells and can, in the absence of APC, enhance the
development of a Th2 phenotype and augment the ex-
pression of the transcription factors c-maf and GATA-3
[21,22].
There are significant differences in HbA1c levels in
T1DM compared to controls and also significant nega-
tive correlation between HbA1c levels T1DM and lev-
els  of  vitamin  D.  High  HbA1c  levels  indicate  poor
glycemic control. A study in the United States had av-
erage high HbA1c levels (9.3±1.9 %) in T1DM with vi-
tamin D deficiency. Vitamin D status is one of the fac-
tors associated with glycemic control in children and
adolescents with T1DM.19 VDR (Vitamin D Receptor)
found on pancreatic beta cells,  suggesting its  role in
glycemic control. Vitamin D inhibits inflammatory cy-
tokine  that  is  involved  in  beta  cell  destruction.  Re-
search by Magee and colleagues examined the associa-
tion  between  vitamin  D and  glycemic  control,  mea-
sured by HbA1c in  type 1 diabetes  in  the  pediatric
population [23].
There are significant differences in the levels of IL-
10 in T1DM compared with controls and significant
positive correlation between the levels of IL-10 T1DM
and levels of vitamin D. Our research is similar with in
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vitro studies  in Turkey whereas  levels  of  IL-10 were
lower compared to the control group (p= 0.033) [24].
IL-10 may provide an important part  of  the anti  in-
flammatory  properties  by inhibiting the transcription
factor. IL-10 is able to inhibit the nuclear translocation
of NF-kB heterodimer. 1,25(OH)2D3 can increase NF-
kB inhibitor (IkB-α) by increasing mRNA stability and
decreasing the phosphorylation of IkB-α. The increase
in IkB-α levels reduces nuclear translocation of NF-kB
and thereby downgrades its activity [25,26].
There  was  a  significant  negative  correlation  be-
tween HbA1c levels and the levels of IL-10. IL-10 was
also significantly associated with HbA1c from a study
performed by Sawa [27]. IL-10 pathway is reportedly
working  on  phosphatidylinositol  3-kinase  (PI3K)
which is responsible for insulin action on glucose up-
take and suppression of gluconeogenesis [27,28].
In  conclusion,  the  present  study  revealed  that
vitamin D deficiency was higher in diabetic children
compared to healthy controls. It will be of interest for
future  studies  to  investigate  whether  vitamin  D
supplementation  will  improve  glycemic  control  and
inflammation  status  in  vitamin  D  deficient  diabetic
children.
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